SPI-BIO is a Drug Development Services Company with expertise in the pharmacokinetics and metabolism of xenobiotics. It develops, manufactures and markets EIA kits and radiolabelled drugs. SPI-BIO also provides a full range of services from the preclinical to clinical trials for the study of potential immunomodulatory and anti-HIV drugs.

SPI-BIO kits are based on the patented acetylcholinesterase technology. This technology offers kinetic superiority, low background, high sensitivity and versatility compared to other labelling enzymes.

SPI-BIO’s product range covers:

• EIA kits
• Eicosanoides
• Interleukins
• Nitric Oxide reagents
• Apoptosis related products
• Hormones

• Service and Consultant activity
• Customised Assays